Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced plans to construct a large-scale commercial drug product fill and finish facility in …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Sika AG (OTCMKTS:SXYAY) Given Average Rating of “Moderate Buy” by Analysts - August 15, 2022
- Family of Blount Co. deputy awaits a new heart - August 14, 2022
- USD/CHF Set to Suffer Heaviest Weekly Loss in Three Months - August 14, 2022